Antimicrobial activity of SCH27899 (Ziracin®), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/Etest method evaluations and quality control guidelines

This publication has 14 references indexed in Scilit:

• Epidemiology, Laboratory Detection, and Therapy of Penicillin-resistant Streptococcal Infections
  Diagnostic Microbiology and Infectious Disease, 1998
• Association Between Decreased Susceptibility to a New Antibiotic for Treatment of Human Diseases, Everninomicin (SCH 27899), and Resistance to an Antibiotic Used for Growth Promotion in Animals, Avilamycin
  Microbial Drug Resistance, 1998
• Nosocomial streptococcal blood stream infections in the SCOPE program: Species occurrence and antimicrobial resistance
  Diagnostic Microbiology and Infectious Disease, 1997
• In vitro evaluation of contemporary β-lactam drugs tested against viridans group and β-haemolytic streptococci
  Diagnostic Microbiology and Infectious Disease, 1997
• The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci
  Clinical Microbiology & Infection, 1997
• Recent Evaluation of Antimicrobial Resistance in β-Hemolytic Streptococci
  Clinical Infectious Diseases, 1997
• Preliminary interpretive criteria for disk diffusion susceptibility testing of SCH 27899, a compound in the everninomicin class of antimicrobial agents
  Diagnostic Microbiology and Infectious Disease, 1995
• Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum
  Clinical Microbiology & Infection, 1995
• Bacteremia Due to Viridans Streptococci That Are Highly Resistant to Penicillin: Increase Among Neutropenic Patients with Cancer
  Clinical Infectious Diseases, 1995
• Structure of everninomicin D
  Journal of the American Chemical Society, 1975